https://www.taxtmi.com/caselaws?id=116930 The Tribunal upheld the Commissioner's decision to classify the product protyne under Chapter Heading 3003.20 as P & P Medicaments, based on evidence of prophylactic use and a license from Drugs Authorities. The Revenue's argument that protyne should be classified as fortified food supplements was rejected, with the Tribunal citing a previous judgment supporting the classification as medicaments. The case underscores the importance of considering intended use and regulatory criteria in product classification, as well as the precedential value of past decisions in similar cases for consistent classification in the pharmaceutical and nutritional industries. en-us Tue, 10 Jan 2006 00:00:00 +0530 Tue, 19 Jun 2012 10:13:39 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=116930 The Tribunal upheld the Commissioner's decision to classify the product protyne under Chapter Heading 3003.20 as P & P Medicaments, based on evidence of prophylactic use and a license from Drugs Authorities. The Revenue's argument that protyne should be classified as fortified food supplements was rejected, with the Tribunal citing a previous judgment supporting the classification as medicaments. The case underscores the importance of considering intended use and regulatory criteria in product classification, as well as the precedential value of past decisions in similar cases for consistent classification in the pharmaceutical and nutritional industries. Case-Laws Central Excise Tue, 10 Jan 2006 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=116930